Cargando…
ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression
Little is known about biological significance of ELK1, a transcriptional factor that activates downstream targets including c-fos proto-oncogene, in bladder cancer. Recent preclinical evidence also suggests the involvement of androgen receptor (AR) signaling in bladder cancer progression. In this st...
Autores principales: | Kawahara, Takashi, Shareef, Hasanain Khaleel, Aljarah, Ali Kadhim, Ide, Hiroki, Li, Yi, Kashiwagi, Eiji, Netto, George J., Zheng, Yichun, Miyamoto, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745768/ https://www.ncbi.nlm.nih.gov/pubmed/26342199 |
Ejemplares similares
-
Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer
por: Kashiwagi, Eiji, et al.
Publicado: (2016) -
Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1
por: Kawahara, Takashi, et al.
Publicado: (2015) -
Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression
por: Kashiwagi, Eiji, et al.
Publicado: (2018) -
ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion
por: Kawahara, Takashi, et al.
Publicado: (2016) -
Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer
por: Jiang, Guiyang, et al.
Publicado: (2021)